Elixinol Wellness Limited
ELLXF
$0.012
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 69.98% | 73.96% | 93.35% | 88.59% | 24.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 69.98% | 73.96% | 93.35% | 88.59% | 24.26% |
| Cost of Revenue | 69.12% | 73.05% | 125.82% | 120.25% | 31.34% |
| Gross Profit | 71.57% | 75.57% | 53.57% | 49.77% | 13.22% |
| SG&A Expenses | 0.28% | 2.63% | -10.43% | -12.64% | -18.55% |
| Depreciation & Amortization | 51.61% | 55.23% | 100.57% | 95.79% | 18.32% |
| Other Operating Expenses | 280.49% | 284.53% | 142.18% | 141.12% | 6.39% |
| Total Operating Expenses | 38.72% | 41.96% | 39.09% | 35.66% | -2.59% |
| Operating Income | 14.56% | 12.56% | 19.15% | 21.15% | 28.81% |
| Income Before Tax | 37.82% | 36.36% | 19.93% | 21.90% | -18.37% |
| Income Tax Expenses | -390,000.00% | -401,000.00% | -57.14% | -57.14% | -- |
| Earnings from Continuing Operations | 125.15% | 125.74% | 19.94% | 21.92% | -18.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 125.15% | 125.74% | 19.94% | 21.92% | -18.39% |
| EBIT | 14.56% | 12.56% | 19.15% | 21.15% | 28.81% |
| EBITDA | 21.96% | 20.15% | 20.81% | 22.76% | 27.98% |
| EPS Basic | 109.89% | 110.38% | 71.03% | 71.71% | 36.36% |
| Normalized Basic EPS | 64.56% | 63.29% | 69.44% | 70.07% | 60.70% |
| EPS Diluted | 109.84% | 110.33% | 70.63% | 71.32% | 36.01% |
| Normalized Diluted EPS | 64.56% | 63.29% | 69.44% | 70.07% | 60.70% |
| Average Basic Shares Outstanding | 151.00% | 151.00% | 177.18% | 177.18% | 85.87% |
| Average Diluted Shares Outstanding | 151.00% | 151.00% | 177.18% | 177.18% | 85.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |